ENLV Stock Price
Enlivex Therapeutics Ltd.
ENLV stock price is $0.22 (-3.06% on the day), giving Enlivex Therapeutics Ltd. a market cap of $4.43M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
ENLV Stock Overview
- Price
- $0.22
- Previous close
- $0.22
- Open
- $0.22
- Market cap
- $4.43M
- P/E ratio
- 0.0
- 52-week range
- $0.22 - $27.15
- 1-year price target
- $80.00
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NSC
- MarketXLS Rank
- 37
About Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. Its product pipeline is the Allocetra, which is in phase II clinical trial for the treatment of organ dysfunction caused by sepsis. The company also develops Allocetra for the treatment of moderate knee osteoarthritis and end-stage knee osteoarthritis which is in phase I/II clinical trial. Enlivex Therapeutics Ltd. is headquartered in Ness Ziona, Israel.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ENLV | $0.22 | -3.1% | 550.39K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Enlivex Therapeutics Ltd. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW